Tag: Death and dying

Physician survey illuminates negative impact of prior authorization

Editor's Note The American Medical Association (AMA) annual, nationwide prior authorization survey reveals that over 90% of physicians believe prior authorization negatively impacts patient clinical outcomes. “More telling,” AMA reported July 17, is the fact that 78% of physicians report that this process “sometimes or often” leads to patients abandoning…

Read More

By: Matt Danford
July 24, 2024
Share

FDA announces Class 1 recalls of ventilator, eye injection kits

Editor's Note The US Food & Drug Administration has designated recalls of Baxter’s Life2000 Ventilator and the I-Pack Injection Kit from Bausch + Lomb and subsidiary Synergetics Inc. as Class 1, the most severe category indicating serious risk of injury or death. According to FDA’s July 15 announcement, the ventilator…

Read More

By: Matt Danford
July 16, 2024
Share

FDA announces Class 1 recalls for ventilator software, electrode pads

Editor's Note The US Food and Drug Administration (FDA) has classified recalls by Hamilton Medical and Megadyne as Class 1 events, the most severe category indicating risk of serious injury or death. According to the agency’s July 11 report, Hamilton Medical is correcting software for its HAMILTON-C6 Medical Ventilator to…

Read More

By: Matt Danford
July 12, 2024
Share

FDA announces Class 1 recalls for upper airway stimulation system, MRI components

Editor's Note A manufacturing defect in a critical component of an upper airway stimulation (UAS) system and coils prone to overheating during magnetic resonance imaging scans (MRIs) prompted The US Food & Drug administration to issue two Class 1 recalls June 8. Class 1 is the most severe category, indicating…

Read More

By: Matt Danford
July 10, 2024
Share

FDA announces Class 1 recalls for ventilators, LVAS monitors

Editor's Note The US Food and Drug Administration has announced class 1 recalls—the most severe category indicating risk of serious injury or death—for Abbot Medical’s HeartMate System Monitor and Philips Respironics OmniLab Advanced+ (OLA+) ventilator. According to the agency’s June 28 report, the recall of the HeartMate System Monitor, part…

Read More

By: Matt Danford
July 1, 2024
Share

Endotracheal tube component failures prompt FDA Class I recall

Editor's Note The US Food & Drug Administration has designated Medline Industries’ recall of the Sub-G Endotracheal Tube with Subglottic Suction, which is used to keep a patients’ airway open, as a class 1, the most severe category indicating risk of serious injury or death. According to the agency’s June…

Read More

By: Matt Danford
June 12, 2024
Share

AI promises to eliminate unnecessary breast cancer biopsies

Editor's Note An AI model that outperformed MRI and ultrasound in identifying patients with axillary breast cancer metastasis shows the technology’s potential to reduce the need for needle or surgical biopsies, according to developers at UT Southwestern Medical Center. In a May 21 report on their new AI model, researchers…

Read More

By: Matt Danford
June 6, 2024
Share

COVID-19 pandemic erased decade of global progress on life expectancy

Editor's Note A nearly 2-year drop in global life expectancy from 2019 to 2021 indicates that the COVID-19 pandemic effectively erased decade of progress, according to The World Health Organization’s 2024 World Health Statistics report. According to May 24 Healio report on WHO’s findings, global life expectancy dropped by 1.8…

Read More

By: Matt Danford
May 30, 2024
Share

Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients

Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…

Read More

By: Matt Danford
May 28, 2024
Share

FDA announces class 1 recall for radiographic breast tissue marker

Editor's Note The US Food and Drug Administration (FDA) has designated the recall of Hologic Inc.’s BioZorb Marker a class 1, indicating a risk of serious injury or death. BioZorb is an implantable radiographic marker used to mark soft tissue (such as breast tissue) for future medical procedures. Provided sterile…

Read More

By: Matt Danford
May 23, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat